Quick Details
- Processing Time:3-7 days
- Port:Shanghai
- Supply Ability: 1000 Boxes Per Month
- Brand Name:Feiyuebio
- CAS No.:FY-EH4200
- Brand Name:Feiyuebio
Product Name
Human PGE2(Prostaglandin E2) ELISA Kit
Catalog NO.
FY-EH4200
Alias
PG-E2 ELISA Kit
Detection Method
Competitive ELISA, Coated with antigen
Application
PGE2 ELISA Kit allows for the in vitro quantitativedetermination of PGE2 concentrations in serum,
plasma, tissue homogenates and other biological
fluids.
Size : 96T
Storage : 2-8 ℃ for 6 months
Sensitivity : 18.75pg/ml
Species : Human
Uniprot : CV %()
Intra-Assay: CV<8%
Inter-Assay: CV<10%
Note
For Research Use Only
Feiyue's Human PGE2(Prostaglandin E2) ELISA Kit
is an ELISA reagent for detection of PGE2(Prostaglandin E2) in human
serum, plasma or cell with sensitivity, specificity and consistency.
This kit uses sandwich ELISA to detect the concentration of PGE2(Prostaglandin
E2).
Standards samples and controls are added to interact with the immobilized
antibody.
The
concentration
of
PGE2(Prostaglandin
E2) in the sample can be calculated by comparing the absorbance of the sample wit
h the standard curve.
The recovery of human PG-E2 spiked to levels throughout the range of the assay in
various matrices was evaluated. Samples were diluted prior to assay as directed
in
the Sample Preparation section.
This kit uses sandwich ELISA to detect the concentration of PGE2(Prostaglandin
E2).
B, Protocol
Please contact:
Tel: 08618062750658 Whatsapp/skype
C, References1, Increased expression of cyclooxygenase‑ 2 in synovium tissues and synovial fluid
from patients with knee osteoarthritis is associated with downregulated
microRNA‑ 758‑ 3p expression Z Liu,Experimental and Therapeutic Medicine,2021
2, Anti‑ inflammatory and anti‑ rheumatic activities in vitro of alkaloids separated
from Aconitum soongoricum Stapf Feicui Zhao,Experimental and Therapeutic
Medicine,2021
3, Preventive Effects of Total Flavonoid C-Glycosides from Abrus mollis on
Nonalcoholic Fatty Liver Disease through Activating the PPARα Signaling Pathway
Hu
XL,Planta Medica,2019
4, Analyses of Clinical Features and Investigations on Potential Mechanisms in
Patients with Alzheimer's Disease and Olfactory Dysfunction Zuo, Li-j